Preferred Label : Naloxone Hydrochloride Dihydride;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : 51481-60-8;
Is substance : O;
Origin ID : M0330065;
UMLS CUI : C0887144;
Exact mapping(s) to DCI
- Manual NTBT mappings (CISMeF)
- Related record
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3505841/fr/ventizolve-naloxone-antidote-des-surdoses-aux-opioides
2024
false
false
false
France
administration, intranasal
treatment outcome
insurance, health, reimbursement
Naloxone Hydrochloride Dihydride
narcotic antagonists
emergency treatment
adult
naloxone
evaluation of the transparency committee
Opiate Overdose
naloxone
antidotes
---
https://www.has-sante.fr/portail/jcms/c_2853739/fr/oxsynia
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
Delayed-Action preparations
drug combinations
Oxycodone Hydrochloride
Oxycodone Hydrochloride
oxycodone and naloxone
analgesics, opioid
analgesics, opioid
Naloxone Hydrochloride Dihydride
Naloxone Hydrochloride Dihydride
narcotic antagonists
narcotic antagonists
insurance, health, reimbursement
adult
pain
restless legs syndrome
narcotics
Cancer Pain
osteoarthritis, knee
osteoarthritis, hip
low back pain
chronic disease
oxycodone naloxone combination
oxycodone
oxycodone
naloxone
naloxone
naloxone
oxycodone
---
http://www.has-sante.fr/portail/jcms/c_2030404/fr/suboxone
http://www.has-sante.fr/portail/jcms/c_666452/suboxone
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/suboxone_ct_5344.pdf
http://www.has-sante.fr/portail/jcms/c_2030404/fr/suboxone-buprenorphine/naloxone-traitement-de-la-dependance-aux-opioides
2015
false
France
French
English
guidelines for drug use
Buprenorphine Hydrochloride
Naloxone Hydrochloride Dihydride
Buprenorphine, Naloxone Drug Combination
buprenorphine, combinations
drug combinations
administration, sublingual
narcotic antagonists
opioid-related disorders
insurance, health, reimbursement
adult
adolescent
treatment outcome
opiate substitution treatment
evaluation of the transparency committee
---
